Hainan Poly Pharm Co Ltd
Hainan Poly Pharm. Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China and internationally. The company's dosage formulations comprise of tablets, capsules, granules, ointments, eye drops, pre-infusion, injection, lyophilization, and oral solutions. It also offers pharmaceutical preparations, active pharmaceutical ingredients, other raw materials, exc… Read more
Hainan Poly Pharm Co Ltd (300630) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: 0.015x
Based on the latest financial reports, Hainan Poly Pharm Co Ltd (300630) has a cash flow conversion efficiency ratio of 0.015x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥44.82 Million) by net assets (CN¥3.01 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Hainan Poly Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2023)
This chart illustrates how Hainan Poly Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Hainan Poly Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hainan Poly Pharm Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BranchOut Food Inc. Common Stock
NASDAQ:BOF
|
-0.219x |
|
Tailyn Technologies
TWO:5353
|
0.043x |
|
Enterprise Group Inc
PINK:ETOLF
|
0.011x |
|
PyroGenesis Canada Inc.
OTCQX:PYRGF
|
0.159x |
|
Take Solutions Limited
NSE:TAKE
|
-0.122x |
|
PIE Industrial Bhd
KLSE:7095
|
0.036x |
|
Grupa Azoty Zaklady Chemiczne Police SA
WAR:PCE
|
0.539x |
|
Bai Sha Technology Co Ltd
TWO:8401
|
0.046x |
Annual Cash Flow Conversion Efficiency for Hainan Poly Pharm Co Ltd (2016–2023)
The table below shows the annual cash flow conversion efficiency of Hainan Poly Pharm Co Ltd from 2016 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | CN¥2.91 Billion | CN¥112.72 Million | 0.039x | -79.66% |
| 2022-12-31 | CN¥2.80 Billion | CN¥534.29 Million | 0.191x | +208.59% |
| 2021-12-31 | CN¥2.54 Billion | CN¥157.03 Million | 0.062x | -62.06% |
| 2020-12-31 | CN¥2.04 Billion | CN¥332.08 Million | 0.163x | -13.35% |
| 2019-12-31 | CN¥1.15 Billion | CN¥215.37 Million | 0.188x | +75.14% |
| 2018-12-31 | CN¥883.26 Million | CN¥94.79 Million | 0.107x | -17.46% |
| 2017-12-31 | CN¥721.37 Million | CN¥93.79 Million | 0.130x | -28.09% |
| 2016-12-31 | CN¥307.12 Million | CN¥55.53 Million | 0.181x | -- |